| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/27/2000 | CN1056879C 重组马立克氏病病毒 Recombinant Marek's Disease Virus |
| 09/27/2000 | CN1056878C Recombinant herpesvirus of turkeys and live vector vaccines derived thereof |
| 09/26/2000 | US6124528 Modification of soluble solids in fruit using sucrose phosphate synthase encoding sequence |
| 09/26/2000 | US6124525 Nucleotide sequence coding an s-adenosyl-l-methionine methythio-adenosine-lyase; for controlling plant development and fruit ripening |
| 09/26/2000 | US6124524 FAE1 genes and their uses |
| 09/26/2000 | US6124449 High affinity TGFβ nucleic acid ligands and inhibitors |
| 09/26/2000 | US6124448 Nucleic acid primers and probes for the mammalian OB gene |
| 09/26/2000 | US6124447 Nucleic acid sequence coding protein which serves as a substrate for cathepsins and has a enzymatic activity which releases phosphoric acid from preferential proteins; for use as an insecticide |
| 09/26/2000 | US6124446 Polynucleotide sequence coding a vacuolar separation polypeptide; for the diagnosis, treatment, and prevention of cancer, inflammatory, lysosomal storage and membrane transport defects; anticarciongenic agents |
| 09/26/2000 | US6124439 OB polypeptide antibodies and method of making |
| 09/26/2000 | US6124433 Polypeptide for use in the detection and monitoring of atherosclerosis, ischemia, hypertension, restenosis, and arterial inflammation |
| 09/26/2000 | US6124430 Amino acid squences useful as a reagent in an immunoassay for measuring and detection of heart hormone protein |
| 09/26/2000 | US6124429 Fibrous protein to be used as biocompatible polymer for surgical sutures, artificial blood vessels and artificial tissues |
| 09/26/2000 | US6124272 Antisense modulation of PDK-1 expression |
| 09/26/2000 | US6124138 Screening or counting one or more polynucleotide sequences in a liquid sample; providing an apparatus comprising a substrate sample distribution network, applying liquid to intake, incubate with binding polymer, measure signal |
| 09/26/2000 | US6124133 Antisense inhibition of fra-1 expression |
| 09/26/2000 | US6124131 Protein associated with incresed oxygen demand; for treatment and prevention of tissues damage caused by lack of oxygen |
| 09/26/2000 | US6124128 Nucleic acid coding green fluorescent protein; for use as marker of gene expression, tracers of cell lineage and as fusion tags to monitor protein localization within viable cells |
| 09/26/2000 | US6124126 Complementary DNA for rice chitinase having lytic activity against moulds and bacteria, and vector containing said complementary DNA and transformant |
| 09/26/2000 | US6124120 Accumulation of a target nucleic acid sequence; mixing primers, polymerase and target sample sequence under conditions that activate replication, recover accumulated sequences |
| 09/26/2000 | US6124119 Nucleotide sequences coding enzymatic polypeptide; for the treatment and prevention of bacterial infection; bactericides |
| 09/26/2000 | US6124118 Receptor recognition factors, protein sequences and methods of use thereof |
| 09/26/2000 | US6124117 Polysaccharide binding fusion proteins and conjugates |
| 09/26/2000 | US6124116 Nucleotide sequence coding human guanidine triphosphatase; for the diagnosis, prevention, or treatment of vision defects, acquired immune deficiency syndrome, and cancer; anticarcinogenic agents |
| 09/26/2000 | US6124115 Production and use of isolated type 5 17β-hydroxysteroid dehydrogenase |
| 09/26/2000 | US6124113 Fermentative carotenoid production |
| 09/26/2000 | US6124101 Diagnosis of thrombosis in a mammals; incubating a sample of fluid with an antibody that preferentially binds a cleaved activation peptide, counting antibody bound cleaved activation peptides, compare to control |
| 09/26/2000 | US6124100 Detecting nervous system disorder; joining a portion of a gene of interest to a duplicated nucleotide sequence, amplify the duplicated sequence using polymerase chain reaction, hybridize product to nervous system gene, analyze results |
| 09/26/2000 | US6124098 Rapid detection of antibiotic resistance in mycobacterium tuberculosis |
| 09/26/2000 | US6124097 Transformed microorganism cells containing nucleotide sequence coding polypeptides of interest |
| 09/26/2000 | US6124095 Human nucleotide pyrophosphohydrolase-2 |
| 09/26/2000 | US6124094 Zoogloeal and hyphomicrobium spp. nucleic acids |
| 09/26/2000 | US6124093 Process for reducing the formation of artifacts during transcription of ribonucleic acids to deoxynucleic acids |
| 09/26/2000 | US6124092 Generating a nucleotide sequencing ladders; mixing recoverable primers with nucleotide sequencing templates, binding nucleotide sequencing ladders to recovery tag binding compounds, recovering nucleotide sequence ladders |
| 09/26/2000 | US6124091 Cell growth-controlling oligonucleotides |
| 09/26/2000 | US6124090 Nucleic acid amplification using single primer |
| 09/26/2000 | US6123949 A vaccine which comprises an effective immunizing amount of the genetically engineered fowlpox virus designated s-fpv-043, useful for immunizing the animal against disease caused by fowlpox virus and newcastle disease virus |
| 09/26/2000 | US6123948 Antigenic determinants of atleast two human papilloma virus proteins selected from l1, l2, e1, e2, e3, e4, e5, e6, e7, in amorphous reaggregated form which when in solution can pass through a sterillization filter used as immunogenic |
| 09/26/2000 | US6123938 Human urinary hyaluronidase |
| 09/26/2000 | CA2283470A1 Screening and therapy for lymphatic disorders involving the flt4 receptor tyrosine kinase (vegfr-3) |
| 09/26/2000 | CA2267014A1 Monocot transformation using acrobacterium |
| 09/26/2000 | CA2103460C Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
| 09/26/2000 | CA2102702C Vitamin k-dependent carboxylase |
| 09/26/2000 | CA2024562C Cho cells transformed with a recombinant plasmid expressing human thyroid peroxidase and preparation thereof |
| 09/26/2000 | CA1341101C Recombinant c-terminal .alpha.- amidating enzyme |
| 09/25/2000 | CA2301335A1 Low temperature expression chitinase cdnas and method for isolating the same |
| 09/25/2000 | CA2301257A1 The ire gene regulating the root-hair growth in arabidopsis |
| 09/21/2000 | WO2000055633A2 Methods of screening for colorectal cancer modulators |
| 09/21/2000 | WO2000055620A1 Non-mammalian transgenic animal having an adult onset neurodegenerative phenotype |
| 09/21/2000 | WO2000055378A1 Lentiviral vector system for high quantity screening |
| 09/21/2000 | WO2000055374A1 Methods and compositions for inhibition of rna splicing |
| 09/21/2000 | WO2000055371A1 27 human secreted proteins |
| 09/21/2000 | WO2000055369A1 Mismatch repair detection |
| 09/21/2000 | WO2000055368A2 Probe/mobility modifier complexes for multiplex nucleic acid detection |
| 09/21/2000 | WO2000055367A1 Detection of melanoma |
| 09/21/2000 | WO2000055366A1 Electropolymerizable film, and method of making and use thereof |
| 09/21/2000 | WO2000055364A2 Genetic analysis |
| 09/21/2000 | WO2000055363A2 Analysis of differential gene expression |
| 09/21/2000 | WO2000055362A1 Deleted sequences in m. bovis bcg/m. bovis or m. tuberculosis, method for detecting mycobacteria using said sequences and vaccines |
| 09/21/2000 | WO2000055361A2 Method for identifying organisms by means of comparative genetic analysis and primers and hybridisation probes for carrying out this method |
| 09/21/2000 | WO2000055353A1 In vitro macromolecule biosynthesis methods using exogenous amino acids and a novel atp regeneration system |
| 09/21/2000 | WO2000055352A2 50 human secreted proteins |
| 09/21/2000 | WO2000055351A1 Human colon cancer associated gene sequences and polypeptides |
| 09/21/2000 | WO2000055350A1 Human cancer associated gene sequences and polypeptides |
| 09/21/2000 | WO2000055346A2 Methods and materials for the rapid and high volume production of a gene knock-out library in an organism |
| 09/21/2000 | WO2000055345A2 Therapy of cancer by insect cells containing recombinant baculovirus encoding genes |
| 09/21/2000 | WO2000055344A1 Adenoviral vector expressing a sv40 t antigen antisense rna |
| 09/21/2000 | WO2000055343A2 Retrovirus producting cells utilizing a high multiplicity of transduction |
| 09/21/2000 | WO2000055342A1 Compositions and methods for helper-free production of recombinant adeno-associated viruses |
| 09/21/2000 | WO2000055341A1 Anti-viral vectors |
| 09/21/2000 | WO2000055340A1 Methods for enhancing the disease resistance of plants |
| 09/21/2000 | WO2000055339A2 Method and device for immobilization of polarizable cells of higher plants by the use of a high frequency ac-field |
| 09/21/2000 | WO2000055338A1 Sesquiterpenoid synthase genes and their use for influencing bitterness and resistance in plants |
| 09/21/2000 | WO2000055337A1 Transgenic plants that are resistant to a broad spectrum of pathogens |
| 09/21/2000 | WO2000055336A2 Ve protein and nucleic acid sequences, compositions, and methods for plant pathogen resistance |
| 09/21/2000 | WO2000055335A1 Pseudotyped lentiviral vectors and uses thereof |
| 09/21/2000 | WO2000055334A1 Novel protease and dna encoding the protease |
| 09/21/2000 | WO2000055333A1 MICROBIAL β-GLUCURONIDASE GENES, GENE PRODUCTS AND USES THEREOF |
| 09/21/2000 | WO2000055332A2 Human regulators of intracellular phosphorylation |
| 09/21/2000 | WO2000055331A1 Genetically modified plants with altered starch |
| 09/21/2000 | WO2000055330A1 Polysaturated fatty acid (pufa) elongase from caenorhabditis elegans |
| 09/21/2000 | WO2000055329A1 Sorbitol dehydrogenase, gene encoding the same and use thereof |
| 09/21/2000 | WO2000055327A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 09/21/2000 | WO2000055326A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 09/21/2000 | WO2000055325A2 Plant centromeres |
| 09/21/2000 | WO2000055324A1 Murine interferon-alpha named also zcyto13 |
| 09/21/2000 | WO2000055323A1 Differential expression of organellar gene products |
| 09/21/2000 | WO2000055322A1 Improved methods for recombinant peptide production |
| 09/21/2000 | WO2000055321A2 Vertebrate protein slit, dna sequence encoding it and uses thereof |
| 09/21/2000 | WO2000055320A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides |
| 09/21/2000 | WO2000055319A1 Methods and compositions for inhibiting neoplastic cell growth |
| 09/21/2000 | WO2000055318A2 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 09/21/2000 | WO2000055317A1 Bsmap, a surface protein expressed specifically in the brain |
| 09/21/2000 | WO2000055316A1 Rna polymerase i transcription factor tif-ia |
| 09/21/2000 | WO2000055315A1 Sf3 promoter and methods of use |
| 09/21/2000 | WO2000055314A2 Inhibitors of endothelin-1 synthesis |
| 09/21/2000 | WO2000055313A1 Photoinhibitory promoter |
| 09/21/2000 | WO2000055312A2 Rt-pcr of clonal neurospheres |
| 09/21/2000 | WO2000055311A2 Gene modification by homologous recombination |
| 09/21/2000 | WO2000055310A1 Improved expression vector for consistent cellular expression of the tet on repressor in multiple cell types |